Cholesterol absorption, synthesis, and LDL metabolism in NIDDM

Diabetes Care

Volumn 20, Issue 1, 1997, Pages 90-95

  Gylling, Helena ^a   Miettinen, Tatu A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CATABOLISM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ABSORPTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0031016436     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.1.90     Document Type: Article

References (43)

1. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 59:8-13, 1979
2. Stamler J, Wentworth D, Neaton J, Schoenberger JA, Feigal D, the Multiple Risk Factor Intervention Trial Research Group: Diabetes and risk of coronary, cardiovascular, and all causes mortality: findings for 356,000 men screened by the Multiple Risk Factor Intervention Trial (MRFIT) (Abstract). Circulation 70 (Suppl. 2):161, 1984
3. Hanefeld M, Schmechel H, Julius U, Fischer S, Schulze J, Schwanebeck U, Lindner J, Hora C, Dude H, The Diabetes Intervention Study Group: Five-year incidence of coronary heart disease related to major risk factors and metabolic control in newly diagnosed non-insulin-dependent diabetes: the Diabetes Intervention Study (DIS). Nutr Metab Cardiovasc Dis 1:135-140, 1991
4. Briones ER, Steiger DL, Palumbo PJ, O'Fallon WM, Langworthy AL, Zimmerman BR, Kottke BA: Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Am J Clin Nutr 44:353-361, 1986
5. Saudek CD, Brach E: Cholesterol metabolism in diabetes. I. The effect of diabetic control on sterol balance. Diabetes 27:1059-1064, 1978
6. Andersen E, Hellström P, Hellström K: Cholesterol and bile acid metabolism in middle-aged diabetics. Diabete Metab 12: 261-267, 1986
7. Kissebah AH: Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 3:619-651, 1987
8. Howard BV Abbott WGH, Beltz WF, Harper IT, Fields RM, Grundy SM, Taskinen M-R: Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36:870-877, 1987
9. Grundy SM, Ahrens EH Jr, Davignon J: The interaction of cholesterol absorption and cholesterol synthesis in man. J Lipid Res 10:304-315, 1969
10. Kesäniemi YA, Miettinen TA: Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest 17:391-395, 1987
11. Miettinen TA, Kesäniemi YA: Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr 49:629-635, 1989
12. Knuts L-R, Rastas M, Haapala P: Micro-Nutrica, Version 1.0. Helsinki, Finland, Kansaneläkelaitos, 1991
13. 3) when used as an index substance. Science 116:634-635, 1952
14. Crouse JR, Grundy SM: Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man. J Lipid Res 19:967-971, 1978
15. Miettinen TA: Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column. Clin Chim Acta 124:245-248, 1982
16. Miettinen TA, Ahrens EH Jr, Grundy SM: Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids. J Lipid Res 6:411-424, 1965
17. Grundy SM, Ahrens EH Jr, Miettinen TA: Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res 6:397-410, 1965
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Polin phenol reagent. J Biol Chem 193:265-275, 1951
19. Gylling H, Vanhanen H, Miettinen TA: Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia. J Lipid Res 34:59-67, 1993
20. Lipid and Lipoprotein Analysis: Manual of Laboratory Operations, Lipid Research Clinic Program. Washington, DC, U.S. Govt. Printing Office, 1974, p. 63-70 (DHEW Publ. No. NIH 75-628)
21. Havekes LM, de Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E: A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res 28:445-463, 1987
22. Miettinen TA, Koivisto P: Non-cholesterol sterols and bile acid production in hypercholesterolemic patients with ileal by-pass. In Bile Acids and Cholesterol in Health and Disease. Paumgartner G, Stiehl A, Gerok W, Eds. Lancaster, PA, MTP, 1983, p. 183-187
23. McFarlane AS: Efficient trace-labeling of proteins with iodine. Nature 182:53, 1958
24. Bilheimer DW, Eisenberg S, Levy RI: The metabolism of very low density lipoproteins. I. Preliminary in vitro and in vivo observations. Biochim Biaphys Acta 260:212-221, 1972
25. 131I-labeled plasma proteins. Phys Med Biol 2:36-53, 1957
26. Tilvis RS, Miettinen TA: Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 43:92-97, 1986
27. Miettinen TA, Tilvis RS, Kesäniemi YA: Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131:20-31, 1990
28. Gylling H, Miettinen TA: Absorption and metabolism of cholesterol in familial hypercholesterolaemia. Clin Sci 76:297-301, 1989
29. Gylling H, Miettinen TA: Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37:773-780, 1994
30. Strandberg TE, Salomaa VV, Vanhanen HT, Miettinen TA: Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men. Diabetes 45:755-761, 1996
31. Miettinen TA, Vanhanen H: Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 105:217-226, 1994
32. Grundy SM, Mok HYI: Determination of cholesterol absorption in man by intestinal perfusion. J Lipid Res 18:263-271, 1977
33. Ponz de Leon M, Iori R, Barbolini G, Pompei G, Zaniol P, Larulli V: Influence of small-bowel transit time on dietary cholesterol absorption in human beings. N Engl J Med 304:102-103, 1992
34. Vuoristo M, Miettinen TA: Cholesterol absorption, elimination and synthesis in coeliac disease. Eur J Clin Invest 12:285-291, 1982
35. Kesaniemi YA, Ehnholm C, Miettinen TA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80:578-581, 1987
36. Miettinen TA: Delaying absorption as a therapeutic pnnciple in metabolic diseases. In Gesellschaft für Fortschritte auf dem Gebiet der Inneren Medizin. Creutzfeld W, Fölsch UR, Eds. Stuttgart, Germany, Georg Thieme Verlag, 1983, p. 118-123
37. Miettinen TA: Regulation of serum cholesterol by cholesterol absorption. Agents Actions Suppl 26:53-65, 1988
38. Kesäniemi YA, Grundy SM: Increased low density lipoprotein production associated with obesity. Arteriosclerosis 3:170-177, 1983
39. Sutherland WH, Scott RS, Lintott CJ, Robertson MC, Stapely SA, Cox C: Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. Horm Metab Res 24:172-175, 1992
40. International Collaborative Study Group: Metabolic epidemiology of plasma cholesterol: mechanisms of variation of plasma cholesterol within populations and between populations. Lancet ii:991-996, 1986
41. Miettinen TA, Gylling H, Vanhanen H, Ollus A: Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 12:1044-1052, 1992
42. Brown WV: Lipoprotein disorders in diabetes mellitus. Med Clin North Am 78:143-161, 1994
43. Vega GL, Grundy SM: Kinetic heterogeneity of low density lipoproteins in primary hypertriglyceridemia. Arteriosclerosis 6:395-406, 1986